Cite

HARVARD Citation

    Talon, B. et al. (2021). Trend in Tyrosine Kinase Inhibitor Utilization, Price, and Out-of-Pocket Costs in Patients With Chronic Myelogenous Leukemia. JCO oncology practice. 17 (11), p. . [Online]. 
  
Back to record